Covid-19 Vaccine

Foreign and Commonwealth Office – in the House of Commons at on 30 June 2020.

Alert me about debates like this

Photo of Jamie Wallis Jamie Wallis Conservative, Bridgend

What diplomatic steps the Government are taking to support the development of a covid-19 vaccine (a) in the UK and (b) throughout the world.

Photo of Andrew Jones Andrew Jones Chair, European Statutory Instruments Committee, Chair, European Statutory Instruments Committee

What diplomatic steps the Government are taking to support the development of a covid-19 vaccine (a) in the UK and (b) throughout the world.

Photo of Christian Wakeford Christian Wakeford Conservative, Bury South

What diplomatic steps the Government are taking to support the development of a covid-19 vaccine (a) in the UK and (b) throughout the world.

Photo of Jo Gideon Jo Gideon Conservative, Stoke-on-Trent Central

What diplomatic steps the Government are taking to support the development of a covid-19 vaccine (a) in the UK and (b) throughout the world.

Photo of Wendy Morton Wendy Morton Parliamentary Under-Secretary (Foreign and Commonwealth Office) (Joint with the Department for International Development)

Finding a covid-19 vaccine is a top priority for the Government. The Prime Minister has set up a vaccine taskforce and appointed Kate Bingham to lead it. The taskforce aims to secure access to promising vaccines for the UK population and to support access to vaccines to help bring the pandemic to an end. We have invested more than £130 million in research for the vaccine front-runners at the University of Oxford and Imperial College, London, and this is in addition to the £250 million that we have contributed to the Coalition for Epidemic Preparedness Innovations and the £1.65 billion to Gavi, the Vaccine Alliance.

Photo of Jamie Wallis Jamie Wallis Conservative, Bridgend

I thank the Minister for her answer. Does she agree that central to the development of a vaccine is ensuring equitable access for all, particularly for those countries whose health systems are most fragile?

Photo of Wendy Morton Wendy Morton Parliamentary Under-Secretary (Foreign and Commonwealth Office) (Joint with the Department for International Development)

That is a really important point. The Prime Minister has made it clear that equitable access is an integral part of the UK’s approach to vaccine development and distribution. Only last weekend, he emphasised how all the world’s leaders have a moral duty to ensure that covid-19 vaccines are truly available to all. That is why the UK has contributed more than £313 million of UK aid to CEPI, the COVID-19 Therapeutics Accelerator, the Access to COVID-19 Tools (ACT) Accelerator, and the Foundation for Innovative New Diagnostics. We have also committed £1.65 billion to Gavi over five years to strengthen immunisation for vaccine preventable disease in vulnerable countries.

Photo of Andrew Jones Andrew Jones Chair, European Statutory Instruments Committee, Chair, European Statutory Instruments Committee

Around the world, there are more than 100 programmes to develop a coronavirus vaccine. Can my hon. Friend confirm that our global diplomatic presence is assisting UK companies and universities to participate in those programmes, basically by using their local networks to highlight the significant expertise that the UK can contribute, but also vice versa to identify where those contacts can contribute to UK-based programmes, because this is truly a global effort?

Photo of Wendy Morton Wendy Morton Parliamentary Under-Secretary (Foreign and Commonwealth Office) (Joint with the Department for International Development)

Yes, our overseas network is working actively around the globe, particularly through our world-leading science and innovation network. The Vaccine Taskforce is also ensuring that work being done to find a vaccine in the UK complements and supports global efforts, including by providing industry and research institutions with resources and support. We welcome the announcement on 4 June of the innovative collaborations between AstraZeneca, CEPI, Gavi and the Serum Institute of India to support the production of 1.3 billion doses for global access to a potential covid-19 vaccine.

Photo of Christian Wakeford Christian Wakeford Conservative, Bury South

Israel is at the forefront of MedTech innovation, which presents many opportunities for the UK’s healthcare system, such as the use of AI technology in diagnostics and screening. Can my hon. Friend tell me what the Government’s plans are to strengthen partnerships between Israeli MedTech companies and UK researchers, particularly in the north-west, to help them not only develop a vaccine but better prepare for the potentiality of any future pandemic?

Photo of Wendy Morton Wendy Morton Parliamentary Under-Secretary (Foreign and Commonwealth Office) (Joint with the Department for International Development)

International collaboration is absolutely vital as we search for a vaccine, and finding a vaccine for covid-19 is a top priority for the Government. The Prime Minister has made it clear that we see vaccines as a global challenge and that no one country can do this alone. That is why the UK has called for clear global commitments from international partners to tackle the pandemic, including through the G7, the G20 and other international forums. The Prime Minister hosted a global vaccine summit on 4 June, which brought together more than 60 countries, including 44 Heads of State and Government, and raised an incredible $8.8 billion to support immunisation of more than 300 million children against vaccine preventable diseases.

Photo of Jo Gideon Jo Gideon Conservative, Stoke-on-Trent Central

Does my hon. Friend agree that Britain has demonstrated its global reach during this pandemic? May I thank the Department for listening to my representations on behalf of my constituents in Stoke-on-Trent Central, who were repatriated from Kathmandu and Durban during lockdown, and ask that the Department use the same global reach to ensure that our world- class vaccine development work benefits the global community?

Photo of Wendy Morton Wendy Morton Parliamentary Under-Secretary (Foreign and Commonwealth Office) (Joint with the Department for International Development)

I know how hard my hon. Friend works in her Stoke-on-Trent Central Constituency. Together, the Foreign Secretary, the ministerial team and the diplomatic network continue to galvanise international support and financial commitments to support research, development and equitable access to vaccines. Through ongoing research at Oxford University and Imperial College, London, the UK is leading the way in developing a coronavirus vaccine. We are also working with international partners to ensure that, wherever a vaccine is discovered, it will benefit the global community as a whole.

Photo of Stephen Doughty Stephen Doughty Shadow Minister (Foreign and Commonwealth Affairs), Shadow Minister (International Development)

Mr Speaker,

“The breadth of the work that DFID is involved in is exemplary…It is firmly in our national interest…As we have seen in recent years with the Ebola crisis”.—[Official Report, 13 June 2016; Vol. 611, c. 262.]

Those are not my words, but those of the Minister. Destabilising Britain’s efforts to tackle disease globally in the middle of a pandemic is not diplomatic;
it is dangerous, and the hostile takeover by the Foreign Secretary has been slammed by 200 leading health and humanitarian agencies, Prime Ministers and MPs from both sides of the House, and those who have assessed the impact of mergers in Australia and Canada. Why does she think she got it wrong, they all got it wrong, and instead, it is Dominic Cummings who is right?

Photo of Wendy Morton Wendy Morton Parliamentary Under-Secretary (Foreign and Commonwealth Office) (Joint with the Department for International Development)

I thank my hon. Friend for his question. We served together on the International Development Committee several years ago, but to be absolutely clear, when it comes to the FCO and DFID merger, as the Prime Minister set out on 16 June we retain our commitment to spending 0.7 % of our gross national income on official development assistance, but it is through closer integration that we will maximise the impact of our aid budget. At the recent Gavi event—the global vaccine summit on 4 June—we mobilised the collective influence of diplomacy and development; it is an excellent example of what the two Departments working together can we achieve.

Prime Minister

http://en.wikipedia.org/wiki/Prime_Minister_of_the_United_Kingdom

Minister

Ministers make up the Government and almost all are members of the House of Lords or the House of Commons. There are three main types of Minister. Departmental Ministers are in charge of Government Departments. The Government is divided into different Departments which have responsibilities for different areas. For example the Treasury is in charge of Government spending. Departmental Ministers in the Cabinet are generally called 'Secretary of State' but some have special titles such as Chancellor of the Exchequer. Ministers of State and Junior Ministers assist the ministers in charge of the department. They normally have responsibility for a particular area within the department and are sometimes given a title that reflects this - for example Minister of Transport.

constituency

In a general election, each Constituency chooses an MP to represent them. MPs have a responsibility to represnt the views of the Constituency in the House of Commons. There are 650 Constituencies, and thus 650 MPs. A citizen of a Constituency is known as a Constituent

Speaker

The Speaker is an MP who has been elected to act as Chairman during debates in the House of Commons. He or she is responsible for ensuring that the rules laid down by the House for the carrying out of its business are observed. It is the Speaker who calls MPs to speak, and maintains order in the House. He or she acts as the House's representative in its relations with outside bodies and the other elements of Parliament such as the Lords and the Monarch. The Speaker is also responsible for protecting the interests of minorities in the House. He or she must ensure that the holders of an opinion, however unpopular, are allowed to put across their view without undue obstruction. It is also the Speaker who reprimands, on behalf of the House, an MP brought to the Bar of the House. In the case of disobedience the Speaker can 'name' an MP which results in their suspension from the House for a period. The Speaker must be impartial in all matters. He or she is elected by MPs in the House of Commons but then ceases to be involved in party politics. All sides in the House rely on the Speaker's disinterest. Even after retirement a former Speaker will not take part in political issues. Taking on the office means losing close contact with old colleagues and keeping apart from all groups and interests, even avoiding using the House of Commons dining rooms or bars. The Speaker continues as a Member of Parliament dealing with constituent's letters and problems. By tradition other candidates from the major parties do not contest the Speaker's seat at a General Election. The Speakership dates back to 1377 when Sir Thomas Hungerford was appointed to the role. The title Speaker comes from the fact that the Speaker was the official spokesman of the House of Commons to the Monarch. In the early years of the office, several Speakers suffered violent deaths when they presented unwelcome news to the King. Further information can be obtained from factsheet M2 on the UK Parliament website.